Replies to post #3195 on Theralase Technologies Inc (TLTFF)

[mystic elf]

The clinical trial on bladder cancer has already proven safety in 5/5 patients...that was the critical challenge.The focus is now to determine the optimal dosage for pivotal ph2 (ph3 is not required) the rest is a slow walk in the park.

Luckily for investors TLT, TLTFF is not a 1 trick pony. I suspect reversing the Warberg Effect with CLT will be embraced by the medical community. Improving results of existing chemo and radiation treatments is a highly significant discovery This is easily testable with existing equipment, off label use. I expect the sales will grow exponentially..near term. Most likely The golden goose for Theralase, and a near term catalyst for investors. best regards